Gene-based clinical trials typically target a very small subset of the patient population. That makes finding patients extremely challenging and implementing effective engagement strategies critical. In addition, regulations regarding the use, storage, and disclosure of genetic test results have changed significantly, resulting in potential compliance risks to clinical trial sponsors.
In this webinar, Karmen Trzupek, M.S., CGC, Director of Rare Disease Genetics Services and Clinical Trial Services at InformedDNA®, explores how to address and overcome challenges in genetics-based clinical trials, using real-life case studies. InformedDNA is the authority on the appropriate use of genetic testing and the leading telemedicine provider of clinical genetics services. Topics to be covered include:
- Effective patient identification
- Strengthening patient engagement and retention
- Collection, use, and disclosure of genetic data
- Planning for a post-market environment
Who should attend? Anyone involved in designing or operating clinical trials for rare disease therapies.